About this trial
The aim of this study is to investigate whether a high definition tDCS-accompanied intensive cognitive training of working memory leads to performance improvement in women with post-chemotherapy cognitive impairment after breast cancer treatment.
Eligibility criteria
Qualifiers
Chemotherapy to treat breast cancer (≥ 6 months post-treatment).
Self-reported concerns regarding cognitive functioning.
Age: 18-65 years.
right-handedness
Disqualifiers
History of dementia before treatment of cancer.
Other neurodegenerative neurological disorders; epilepsy or history of seizures.
Severe and untreated medical conditions that preclude participation in the training, as determined by responsible physician.
History of moderate to severe substance use disorder according to DSM-5
Trial design
Treatments tested in this trial
- Anodal tDCS
- Sham tDCS
- Intensive cognitive training
Treatment groups
Sponsors and collaborators
University Medicine Greifswald
Lead sponsor
University of Greifswald
Collaborator